THE BUSINESS OF BIOTECH

54:23 24_01_BoB_1280x720_Ep262
The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics

On this week's episode, Roger Cone, Ph.D., Founder and Chair of the Scientific Advisory Board at Courage Therapeutics, talks about discovering obesity-related protein receptors in the brain, how he spun his academic discoveries out into a biotech company developing ne...

ABOUT THE BUSINESS OF BIOTECH

Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.

FEATURED GUESTS

Roger Cone
Courage Therapeutics
PLAY
Amber Salzman
Epicrispr Biotechnologies
PLAY
Jennifer Hawks Bland
NewYorkBIO
PLAY
Barry Quart
Connect Biopharma
PLAY
Thomas Levenson
PLAY
Srinivas Rao
atai Life Sciences
PLAY
Yaniv Sneor
Native State Therapeutics
PLAY
Michelle Werner
Alltrna
PLAY
Mark Eisner
Vir Biotechnology
PLAY

MEET YOUR HOST

Ben ComerBen Comer is chief editor of Life Science Leader magazine. He has covered the biopharmaceutical, medtech and medical device industries for 15 years as a reporter and editor, and worked as a senior manager in PwC’s Health Research Institute.

Interested in joining us on air? Contact us